Ying Huang, Legend CEO
April 19, 2023 03:26 PM EDT
Financing
Cell/Gene Tx

Leg­end rais­es $200M from pri­vate in­vestor af­ter con­fer­ence leaks PhI­II Carvyk­ti da­ta

Kyle LaHucik

Senior Reporter

A day af­ter a leaked da­ta pre­sen­ta­tion show­ing pos­i­tive Phase III re­sults for Leg­end Biotech’s CAR-T treat­ment Carvyk­ti, the com­pa­ny said it has raised …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Gilead will close Philadel­phia, Seat­tle of­fices as part of job re­duc­tions

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times